Médecine

Paramédical

Autres domaines


S'abonner

Total hip arthroplasty survival in femoral head avascular necrosis versus primary hip osteoarthritis: Case-control study with a mean 10-year follow-up after anatomical cementless metal-on-metal 28-mm replacement - 01/12/16

Doi : 10.1016/j.otsr.2016.08.021 
D. Ancelin , N. Reina, E. Cavaignac, S. Delclaux, P. Chiron
 Département de Chirurgie Orthopédique, Traumatologique et Réparatrice, Hôpital Pierre-Paul-Riquet, place du Dr-Baylac, TSA 40 031, 31059 Toulouse cedex 9, France 

Corresponding author. Tel.: +33 561 775 576; fax: +33 561 775 696.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Total hip arthroplasty is the most widely used procedure to treat avascular necrosis (AVN) of the femoral head. Few studies have compared the outcomes of THA in femoral head AVN and primary hip osteoarthritis. Therefore we performed a case-control study to compare THA for femoral head AVN vs. primary hip osteoarthritis in terms of: (1) prosthesis survival, (2) complication rates, (3) functional outcomes and radiographic outcomes, (4) and to determine whether specific risk factors for THA failure exist in femoral head AVN.

Hypothesis

THA survival is similar in femoral head AVN and primary hip osteoarthritis.

Material and methods

We compared two prospective cohorts of patients who underwent THA before 65 years of age, one composed of cases with femoral head AVN and the other of controls with primary hip osteoarthritis. In both cohorts, a cementless metal-on-metal prosthesis with a 28-mm cup and an anatomical stem was used. Exclusion criteria were THA with other types of prosthesis, posttraumatic AVN, and secondary osteoarthritis. With α set at 5%, to obtain 80% power, 246 patients were required in all. Prosthesis survival was assessed based on time to major revision (defined as replacement of at least one implant fixed to bone) and time to aseptic loosening. The other evaluation criteria were complications, Postel-Merle d’Aubigné (PMA) score, and the Engh and Agora Radiographic Assessment (ARA) scores for implant osseointegration.

Results

The study included 282 patients, 149 with AVN and 133 with osteoarthritis. Mean age was 47.8±10.2 years (range, 18.5–65) and mean follow-up was 11.4±2.8 years (range, 4.5–18.3 years). The 10-year survival rates were similar in the two groups: for major revision, AVN group, 92.5% (95% confidence interval [95% CI], 90.2–94.8) and osteoarthritis group, 95.3% (95% CI, 92.9–97.7); for aseptic loosening, AVN group, 98.6% (95% CI, 97.6–98.6) and osteoarthritis, 99.2% (95% CI, 98.4–100). The AVN group had higher numbers of revision for any reason (19 vs. 6, P=0.018) and for dislocation (8 vs. 1, P=0.031). Mean PMA scores at last follow-up were comparable in the AVN group (17.65±1.27 [range, 10–18]) and osteoarthritis group (17.59±1.32 [range, 14–18]) (P=0.139). Osseointegration was also similar in the two groups: global Engh score, 26.51±1.81 (range, 14–27) for AVN and 26.84±0.91 (range, 19.5–27) for osteoarthritis (P=0.065); femoral ARA score, 5.83±0.46 (range, 3–6) for AVN and 5.90±0.42 (range, 3–6) for osteoarthritis (P=0.064); and cup ARA score, 5.74±0.67 (range, 3–6) for AVN and 5.78±0.66 (range, 3–6) for osteoarthritis (P=0.344).

Discussion

Survival in this study was good and consistent with recent data on AVN, with no difference between AVN and osteoarthritis. Revisions for any cause or for dislocation were more common after THA for AVN. Functional outcomes were similar in the AVN and osteoarthritis groups. An anatomical cementless prosthesis combined with metal-on-metal 28-mm bearing provides durable good outcomes.

Level of evidence

III, non-randomized comparison of two prospective cohorts.

Le texte complet de cet article est disponible en PDF.

Keywords : Avascular necrosis of femoral head, Total hip arthroplasty, Survival analysis, Revision surgery, Comparative study


Plan


© 2016  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 102 - N° 8

P. 1029-1034 - décembre 2016 Retour au numéro
Article précédent Article précédent
  • Scoring system to predict hemorrhage in pelvic ring fracture
  • T. Ohmori, T. Matsumoto, T. Kitamura, R. Tamura, K. Tada, T. Inoue, T. Hayashi, K. Numoto, T. Tokioka
| Article suivant Article suivant
  • Does a titanium sleeve reduce the frequency of pseudotumors in metal-on-metal total hip arthroplasty at 5–7 years follow-up?
  • M.H. Hjorth, N. Egund, I. Mechlenburg, J. Gelineck, S.S. Jakobsen, K. Soballe, M. Stilling

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement ou un achat à l’unité.

Déjà abonné à cette revue ?

;

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.